No Data
No Data
Earnings Preview: Zai Lab to Report Financial Results Pre-market on May 08
Express News | U.S.-listed Chinese stocks surge at the opening, with Alibaba up over 4%.
Express News | U.S.-listed Chinese stocks surge in overnight trading, with Alibaba up over 4%.
Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025
BofA Securities Maintains Zai Lab(ZLAB.US) With Hold Rating, Maintains Target Price $36.1
ZAI LAB (09688.HK) plans to hold a Board of Directors meeting on May 8 to approve the first-quarter performance.
Gelonghui reported on April 24 that ZAI LAB (09688.HK) announced that the Board of Directors' Audit Committee will review and approve on May 8, 2025 (Thursday) the company's and its subsidiaries' unaudited quarterly performance for the three months ending March 31, 2025, prepared in accordance with US Generally Accepted Accounting Principles and applicable rules of the USA Securities and Exchange Commission ("first quarter performance") and its release.